ALMIA Submits Medicare Advantage Broker Policy Comments to HHS Panel
The Alliance of Licensed Medicare Insurance Agencies filed public comments with an HHS advisory committee ahead of its November 9 meeting on Medicare Advantage broker policy.
The Alliance of Licensed Medicare Insurance Agencies (ALMIA) has formally submitted public comments to the Department of Health and Human Services Healthcare Advisory Committee, the organization announced Wednesday, as the panel prepares for its November 9 meeting focused on Medicare Advantage broker regulations.
ALMIA, which represents licensed agencies that sell Medicare insurance products, said its submission is part of ongoing engagement with the committee's workstream focused on strengthening Medicare Advantage. The move signals an intensifying effort by the brokerage community to shape federal policy governing how agents and agencies are compensated and regulated within the Medicare Advantage marketplace.
Read more Labor Dept. Warns Employers Over Inaccurate Health Plan Provider Directories →
Medicare Advantage, the privately administered alternative to traditional Medicare, has drawn heightened regulatory scrutiny in recent years as enrollment has surged and concerns have mounted over marketing practices and broker incentives. Advisory committee proceedings such as this one feed into the broader federal rulemaking process that can affect millions of Medicare beneficiaries and the agencies that serve them.
By entering comments into the public record ahead of the scheduled meeting, ALMIA aims to ensure that the perspective of licensed insurance agencies is considered as policymakers weigh potential changes to broker compensation structures and oversight requirements. The outcome of such deliberations could carry significant implications for how Medicare plans are marketed and sold across the country.
Continue reading at All Financial Services & Investing